These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33174608)

  • 1. Tripartite motif‑containing 14 regulates cell proliferation and apoptosis in cervical cancer via the Akt signaling pathway.
    Diao W; Zhu C; Guo Q; Cao Y; Song Y; Feng H; Li J; Xue X; Lu P
    Mol Med Rep; 2020 Dec; 22(6):5145-5154. PubMed ID: 33174608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM14 regulates melanoma malignancy via PTEN/PI3K/AKT and STAT3 pathways.
    Chen J; Huang L; Quan J; Xiang D
    Aging (Albany NY); 2021 May; 13(9):13225-13238. PubMed ID: 33982666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mesenchymal stem cells derived exosomes inhibit the growth of acute myeloid leukemia cells via regulating miR-23b-5p/TRIM14 pathway.
    Cheng H; Ding J; Tang G; Huang A; Gao L; Yang J; Chen L
    Mol Med; 2021 Oct; 27(1):128. PubMed ID: 34656078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.
    Xu G; Guo Y; Xu D; Wang Y; Shen Y; Wang F; Lv Y; Song F; Jiang D; Zhang Y; Lou Y; Meng Y; Yang Y; Kang Y
    Sci Rep; 2017 Feb; 7():42411. PubMed ID: 28205534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK/mTOR pathway.
    Xiao F; Ouyang B; Zou J; Yang Y; Yi L; Yan H
    Drug Dev Res; 2020 Aug; 81(5):544-550. PubMed ID: 32096264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA circ_0048764 promotes the development of breast cancer by regulating microRNA-1296-5p/tripartite motif containing 14 axis.
    Xie F; Xiong Y; Yan J; Wang L; Yan W
    Bioengineered; 2022 Feb; 13(2):1963-1974. PubMed ID: 34787066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelial‑to‑mesenchymal transition via activation of AKT signaling regulated by miR‑195‑5p.
    Wang F; Ruan L; Yang J; Zhao Q; Wei W
    Oncol Rep; 2018 Dec; 40(6):3273-3284. PubMed ID: 30272351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splicing Factor PTBP1 Silencing Induces Apoptosis of Human Cervical Cancer Cells via PI3K/AKT Pathway and Autophagy.
    Liu T; Zhou Y; Chen L; Liu Q; Hu D; Huang R; Ji H; Lin Y; Sun Y
    Front Biosci (Landmark Ed); 2024 Aug; 29(8):289. PubMed ID: 39206910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripartite motif containing 14: An oncogene in papillary thyroid carcinoma.
    Sun W; Wang Y; Li D; Wu Y; Ji Q; Sun T
    Biochem Biophys Res Commun; 2020 Jan; 521(2):360-367. PubMed ID: 31668806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
    Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
    Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
    Xu H; Zhu J; Hu C; Song H; Li Y
    J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
    Liu H; Zhang L; Ding X; Sui X
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway.
    Fu K; Zhang L; Liu R; Shi Q; Li X; Wang M
    World J Surg Oncol; 2020 May; 18(1):115. PubMed ID: 32473637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
    Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression.
    Sui X; Wang Y; Liu H
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR‑379‑5p inhibits cell proliferation and promotes cell apoptosis in non‑small cell lung cancer by targeting β‑arrestin‑1.
    Jiang Y; Zhu P; Gao Y; Wang A
    Mol Med Rep; 2020 Dec; 22(6):4499-4508. PubMed ID: 33173959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway.
    Diao W; Guo Q; Zhu C; Song Y; Feng H; Cao Y; Du M; Chen H
    BMC Cancer; 2020 Aug; 20(1):741. PubMed ID: 32770981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
    Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
    J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.